Michael S. Lauer, MD
Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-0422.
Requests for Single Reprints: Michael S. Lauer, MD, Office of Extramural Research, National Institutes of Health, Building 1, 1 Center Drive, Bethesda, MD 20892; e-mail, email@example.com.
Lauer MS. PCSK9 Inhibitors: Lots of Work Done, Lots More to Do. Ann Intern Med. 2016;164:624–625. [Epub ahead of print 22 March 2016]. doi: https://doi.org/10.7326/M16-0422
Download citation file:
Published: Ann Intern Med. 2016;164(9):624-625.
Published at www.annals.org on 22 March 2016
Cardiology, Coronary Risk Factors, Dyslipidemia.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use